Viemed Healthcare, Inc

(NASDAQ:VMD)

Latest On Viemed Healthcare, Inc (VMD):

Date/Time Type Description Signal Details
2023-05-18 12:15 ESTNewsViemed Healthcare: Superb Growth Expectations, Reiterate BuyN/A
2023-05-09 19:33 ESTNewsViemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $39.56M beats by $1.09MN/A
2023-05-09 19:32 ESTNewsViemed Healthcare, Inc. (VMD) Q1 2023 Earnings Call TranscriptN/A
2023-04-18 16:18 ESTNewsViemed Healthcare agrees to acquire Tennessee-based Home Medical ProductsN/A
2023-03-03 13:17 ESTNewsViemed Healthcare, Inc. (VMD) Q4 2022 Earnings Call TranscriptN/A
2023-03-02 23:09 ESTNewsViemed Healthcare Q4 results mixedN/A
2023-02-22 05:49 ESTNewsViemed Healthcare: Steady As She GoesN/A
2023-01-12 15:22 ESTNewsViemed on the rise following $2M investment in ModoHealthN/A
2022-11-30 07:47 ESTNewsViemed Healthcare enters into new syndicated credit facilitiesN/A
2022-11-22 09:51 ESTNewsViemed Healthcare: Revising Case To BuyN/A
2022-11-03 00:38 ESTNewsViemed Healthcare, Inc. (VMD) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 17:03 ESTNewsViemed Healthcare GAAP EPS of $0.03 misses by $0.01, revenue of $35.8M beats by $1MN/A
2022-11-01 01:11 ESTNewsViemed Healthcare Q3 2022 Earnings PreviewN/A
2022-08-25 19:51 ESTNewsViemed Healthcare: Comments On Q2 EarningsN/A
2022-08-04 03:13 ESTNewsViemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-02 22:21 ESTNewsViemed Healthcare GAAP EPS of $0.02 misses by $0.03, revenue of $33.1M beats by $0.8MN/A
2022-08-02 07:13 ESTNewsViemed Healthcare Q2 2022 Earnings PreviewN/A
2022-05-08 05:30 ESTNewsViemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 22:05 ESTNewsViemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $32.25M beats by $1.12MN/A
2022-05-03 22:05 ESTNewsViemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $32.26M beats by $1.13MN/A
2022-05-03 04:01 ESTNewsViemed Healthcare Q1 2022 Earnings PreviewN/A
2022-03-08 21:26 ESTNewsViemed Healthcare GAAP EPS of $0.10 beats by $0.04, revenue of $31.96M beats by $2.23MN/A
2022-03-08 21:25 ESTNewsViemed Healthcare announces share buyback planN/A
2022-03-08 21:25 ESTNewsViemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-08 03:35 ESTNewsViemed Healthcare GAAP EPS of $0.10 misses by $0.13, revenue of $31.96M misses by $82.87MN/A
2021-12-30 03:13 ESTNewsViemed Healthcare: New Bullish Trend Has Just BegunN/A
2021-11-24 07:38 ESTNewsViemed Healthcare (VMD) Investor PresentationN/A
2021-11-10 17:58 ESTNewsViemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 05:49 ESTNewsViemed Healthcare 3Q 2021 Earnings PreviewN/A
2021-11-02 05:49 ESTNewsViemed Healthcare EPS in-line, beats on revenueN/A
2021-11-02 05:49 ESTNewsViemed Healthcare EPS misses by $0.01, beats on revenue; issues Q4 guidanceN/A
2021-08-04 17:23 ESTNewsViemed Healthcare's (VMD) CEO Casey Hoyt on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-03 01:38 ESTNewsViemed Healthcare EPS beats by $0.01, beats on revenueN/A
2021-05-06 21:10 ESTNewsViemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call PresentationN/A
2021-05-04 07:40 ESTNewsViemed Healthcare EPS misses by $0.01, revenue in-lineN/A
2021-04-19 19:01 ESTNewsCove Street Capital Discusses ViemedN/A
2021-03-07 04:37 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 07:46 ESTNewsViemed Healthcare EPS beats by $0.07, beats on revenueN/A
2021-03-04 10:57 ESTNewsViemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-04 04:49 ESTFinancialsCompany financials have been released.Neutral
2021-01-12 00:23 ESTNewsStrong Execution By Insider-Owners Ensures Viemed's GrowthN/A
2020-11-26 21:57 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 22:14 ESTNewsViemed Healthcare, Inc.'s (VMD) CEO Casey Hoyt on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-08 01:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 21:19 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 18:18 ESTNewsViemed Healthcare EPS misses by $0.02, beats on revenueN/A
2020-09-26 14:30 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 08:53 ESTNewsViemed: A Healthcare Stock To WatchN/A
2020-09-17 06:35 ESTFinancialsCompany financials have been released.Neutral

About Viemed Healthcare, Inc (VMD):

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.

See Advanced Chart

General

  • Name Viemed Healthcare, Inc
  • Symbol VMD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 511
  • Fiscal Year EndDecember
  • IPO Date2017-12-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Providers & Services
  • Web URLhttp://www.viemed.com
View More

Valuation

  • Trailing PE 36.64
  • Forward PE 39.84
  • Price/Sales (Trailing 12 Mt.) 3.19
  • Price/Book (Most Recent Quarter) 5.01
  • Enterprise Value Revenue 2.93
  • Enterprise Value EBITDA 10.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 24%
  • Operating Margin 16%
  • Return on Assets 13%
  • Return on Equity 50%
  • Revenue 131.31 million
  • Earnings Per Share $0.25
  • Revenue Per Share $3.39
  • Gross Profit 80.11 million
  • Quarterly Earnings Growth 45.5%
View More

Highlights

  • Market Capitalization 360.09 million
  • EBITDA 30.54 million
  • PE Ratio 31.14
  • Book Value Per Share $1.15
View More

Share Statistics

  • Shares Outstanding 39.56 million
  • Shares Float 35.06 million
  • % Held by Insiders 1142%
  • % Held by Institutions 55.79%
  • Shares Short 1.35 million
  • Shares Short Prior Month 1.28 million
  • Short Ratio 6.18
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.78
  • 52 Week High $11.93
  • 52 Week Low $3.52
  • 50 Day Moving Average 9.85
  • 200 Day Moving Average 9.1
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Viemed Healthcare, Inc (VMD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Viemed Healthcare, Inc (VMD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-03$N/A$0.12$0.05125.14%
2020-09-302020-11-04$N/A$0.07$0.09-17.65%
2020-06-302020-08-04$42.85 million$0.48$0.2684.62%
2020-03-312020-05-04$23.81 million$0.11$0.0837.5%
2019-12-312020-03-03$13.74 million$0.06$0.07-14.29%
2019-09-302019-11-04$23.53 million$0.07$0.0616.67%
2019-06-302019-08-09$22.55 million$0.05$0.06-16.67%
2019-03-312019-05-06$20.44 million$0.05$0.08-37.5%
2018-12-312019-02-27$18.49 million$0.08$0.080%
2018-09-302018-11-05$17.16 million$0.06$0.060%
2018-06-302018-08-13$15.51 million$0.06
2018-03-312018-05-07$14.11 million$0.06

Viemed Healthcare, Inc (VMD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Viemed Healthcare, Inc (VMD) Chart:

Viemed Healthcare, Inc (VMD) News:

Below you will find a list of latest news for Viemed Healthcare, Inc (VMD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Viemed Healthcare, Inc (VMD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.50CALL0 0980.14TRUE00
2025-04-1750CALL0 093.48TRUE00
2025-04-177.50CALL0 042.55FALSE00
2025-04-17100CALL0 0286.8FALSE00
2025-04-1712.50CALL0 0336.63FALSE00
2025-04-17150CALL0 0373.08FALSE00
2025-04-172.50PUT0 01098.2FALSE00
2025-04-1750PUT0 0460.72FALSE00
2025-04-177.50PUT0 067.31TRUE00
2025-04-17100PUT0 0126.59TRUE00
2025-04-1712.50PUT0 0191.37TRUE00
2025-04-17150PUT0 0238.15TRUE00
2025-05-162.55.16CALL0 1612.34TRUE00
2025-05-1653.8CALL0 2158.71TRUE00
2025-05-167.51.05CALL0 1536.71FALSE00
2025-05-16100CALL0 0221.83FALSE00
2025-05-1612.50.25CALL0 1109.19FALSE00
2025-05-16150CALL0 0133.07FALSE00
2025-05-1617.50CALL0 0105.18FALSE00
2025-05-162.50PUT0 0268.33FALSE00
2025-05-1650PUT0 0127.65FALSE00
2025-05-167.50.38PUT0 257.17TRUE00
2025-05-16100PUT0 0104.56TRUE00
2025-05-1612.50PUT0 0153.83TRUE00
2025-05-16150PUT0 0181.06TRUE00
2025-05-1617.50PUT0 0140.99TRUE00
2025-08-152.50CALL0 070.09TRUE00
2025-08-1550CALL0 0104.26TRUE00
2025-08-157.50CALL0 034.54FALSE00
2025-08-15100.58CALL0 440.67FALSE00
2025-08-1512.50CALL0 0176.84FALSE00
2025-08-15150CALL0 0194.56FALSE00
2025-08-1517.50CALL0 0208.49FALSE00
2025-08-152.50PUT0 0841.9FALSE00
2025-08-1550PUT0 094.98FALSE00
2025-08-157.50PUT0 046.46TRUE00
2025-08-15100PUT0 098.38TRUE00
2025-08-1512.50PUT0 0103.84TRUE00
2025-08-15150PUT0 0114.1TRUE00
2025-08-1517.50PUT0 0109.84TRUE00

Latest VMD Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST200$5.695
Jun 13, 2022 7:59 PM EST400$5.7
Jun 13, 2022 7:59 PM EST200$5.695
Jun 13, 2022 7:59 PM EST100$5.705
Jun 13, 2022 7:59 PM EST9$5.7

Viemed Healthcare, Inc (VMD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000033/0001729149-20-000033-index.htm
2019-05-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1729149/000000000019009166/0000000000-19-009166-index.htm
2020-09-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1729149/000000000020008400/0000000000-20-008400-index.htm
2020-01-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1729149/000091384920000009/0000913849-20-000009-index.htm
2019-05-03DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1729149/000114036119008363/0001140361-19-008363-index.htm
2019-06-26DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1729149/000114036119011692/0001140361-19-011692-index.htm
2019-06-26DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1729149/000114036119011697/0001140361-19-011697-index.htm
2019-07-1010-12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1729149/000114036119012755/0001140361-19-012755-index.htm
2019-07-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1729149/000114036119013442/0001140361-19-013442-index.htm
2019-08-0110-12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1729149/000114036119014025/0001140361-19-014025-index.htm
2019-08-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1729149/000114036119014437/0001140361-19-014437-index.htm
2019-08-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1729149/000114036119014466/0001140361-19-014466-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000114036119014661/0001140361-19-014661-index.htm
2019-08-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1729149/000114036119015469/0001140361-19-015469-index.htm
2019-08-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1729149/000114036119015470/0001140361-19-015470-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000114036119016991/0001140361-19-016991-index.htm
2020-09-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1729149/000114036120019719/0001140361-20-019719-index.htm
2020-09-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1729149/000114036120019947/0001140361-20-019947-index.htm
2018-02-01DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1729149/000118374018000020/0001183740-18-000020-index.htm
2019-08-07CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1729149/000135445719000402/0001354457-19-000402-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1729149/000172914919000005/0001729149-19-000005-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914919000008/0001729149-19-000008-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914919000010/0001729149-19-000010-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914919000012/0001729149-19-000012-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1729149/000172914919000016/0001729149-19-000016-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000002/0001729149-20-000002-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1729149/000172914920000005/0001729149-20-000005-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000008/0001729149-20-000008-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000011/0001729149-20-000011-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000013/0001729149-20-000013-index.htm
2020-04-2810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1729149/000172914920000015/0001729149-20-000015-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000017/0001729149-20-000017-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1729149/000172914920000019/0001729149-20-000019-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000021/0001729149-20-000021-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000023/0001729149-20-000023-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000026/0001729149-20-000026-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000029/0001729149-20-000029-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000031/0001729149-20-000031-index.htm
2020-06-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000033/0001729149-20-000033-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1729149/000172914920000035/0001729149-20-000035-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000038/0001729149-20-000038-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000040/0001729149-20-000040-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1729149/000172914920000047/0001729149-20-000047-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000049/0001729149-20-000049-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1729149/000172914920000052/0001729149-20-000052-index.htm
2020-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1729149/999999999520002416/9999999995-20-002416-index.htm
2019-08-08SEC STAFF SEC Staff Action: ORDERhttps://www.sec.gov/Archives/edgar/data/1729149/999999999719006414/9999999997-19-006414-index.htm